Restructuring and Rationalisation Expenses In 2007, restructuring and rationalisation expenses comprised $45m relating to the earnings improvement programmeless $3m relatingto the writebackof prioryears provisions.
In 2005, the Group incurred restructuring and rationalisation expenses comprising two items.
$68m related to the Groups decision to exit the tissue engineering operations within Advanced Wound Management.
The operations were sold in May 2006 for a nominal amount with the Group retaining certain liabilities including future obligations.
The components of the exit costs were $24m to write down intangible assets comprising patents and other intellectual property to their value in use of nil, $3m to write down plant and equipment to nil, a $5m inventory write down, $9m for redundancy payments, $17m for onerous lease obligations and $10m for other items.
In addition, in 2005, $16m related to the closure of the Andover, Massachusetts endoscopy manufacturing facility, which was completed in 2007.
The components were $5m to write down freehold land and buildings to fair value less costs to sell based on an independent valuation, $8m for redundancypayments and $3m forotheritems.
Legal Settlement The legal settlement of $30m in 2007 relates to the civil settlement agreed with the US Department of Justice .
In 2004, there was a macrotextured claim of $154m which represented provision of $25m for the amount due from excess layer insurers who had declined insurance coverage for claims relating to macrotextured knee revisions together with an estimate of $129m for the cost of settlements with patients likely to arise in the future and assuming that insurancecover remains unavailable see Note 34.
In 2007, this provisionwas increased by $22m to reflect an increase in anticipated costs to settle outstanding and future claims, offset bya receipt of $22m froma successful legal settlement.
The gross interest receivable on these swaps was $13m 2006 $18m, 2005 $58m and the gross interest payable was $13m 2006 $15m, 2005$34m.
